190 related articles for article (PubMed ID: 8652540)
1. Distortion of the active site of chymotrypsin complexed with a serpin.
Plotnick MI; Mayne L; Schechter NM; Rubin H
Biochemistry; 1996 Jun; 35(23):7586-90. PubMed ID: 8652540
[TBL] [Abstract][Full Text] [Related]
2. Role of the P2 residue in determining the specificity of serpins.
Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
[TBL] [Abstract][Full Text] [Related]
3. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
4. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
6. The structure of a Michaelis serpin-protease complex.
Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown.
Plotnick MI; Samakur M; Wang ZM; Liu X; Rubin H; Schechter NM; Selwood T
Biochemistry; 2002 Jan; 41(1):334-42. PubMed ID: 11772033
[TBL] [Abstract][Full Text] [Related]
8. Structural change in alpha-chymotrypsin induced by complexation with alpha 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis.
Stavridi ES; O'Malley K; Lukacs CM; Moore WT; Lambris JD; Christianson DW; Rubin H; Cooperman BS
Biochemistry; 1996 Aug; 35(33):10608-15. PubMed ID: 8718849
[TBL] [Abstract][Full Text] [Related]
9. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
Shin JS; Yu MH
J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
[TBL] [Abstract][Full Text] [Related]
10. Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction.
Lukacs CM; Rubin H; Christianson DW
Biochemistry; 1998 Mar; 37(10):3297-304. PubMed ID: 9521649
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
12. Structure of a serpin-protease complex shows inhibition by deformation.
Huntington JA; Read RJ; Carrell RW
Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
14. Role of Lys335 in the metastability and function of inhibitory serpins.
Im H; Yu MH
Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
[TBL] [Abstract][Full Text] [Related]
15. Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities.
Hook VY; Hwang SR
Biol Chem; 2002; 383(7-8):1067-74. PubMed ID: 12437089
[TBL] [Abstract][Full Text] [Related]
16. Resistance of cathepsin L compared to elastase to proteolysis when complexed with the serpin endopin 2C, and recovery of cathepsin L activity.
Hwang SR; Stoka V; Turk V; Hook V
Biochem Biophys Res Commun; 2006 Feb; 340(4):1238-43. PubMed ID: 16414353
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
Mast AE; Enghild JJ; Pizzo SV; Salvesen G
Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
[TBL] [Abstract][Full Text] [Related]
18. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.
Olson ST; Bock PE; Kvassman J; Shore JD; Lawrence DA; Ginsburg D; Björk I
J Biol Chem; 1995 Dec; 270(50):30007-17. PubMed ID: 8530403
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
[TBL] [Abstract][Full Text] [Related]
20. Murine serpin 2A is a redox-sensitive intracellular protein.
Morris EC; Dafforn TR; Forsyth SL; Missen MA; Horvath AJ; Hampson L; Hampson IN; Currie G; Carrell RW; Coughlin PB
Biochem J; 2003 Apr; 371(Pt 1):165-73. PubMed ID: 12470299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
